Advances in biological activities of essential oils

dc.authorscopusid56468057800
dc.authorscopusid18633264700
dc.authorscopusid57219536885
dc.authorscopusid23488716100
dc.contributor.authorMutlu İngök, Ayşegül
dc.contributor.authorDevecioğlu, Dilara
dc.contributor.authorDikmetaş, Dilara Nur
dc.contributor.authorKarbancıoğlu Güler, Funda
dc.date.accessioned2023-07-26T11:54:27Z
dc.date.available2023-07-26T11:54:27Z
dc.date.issued2022
dc.departmentDÜ, Akçakoca Meslek Yüksekokulu, Gıda İşleme Bölümüen_US
dc.description.abstractEssential oils (EOs), which are secondary metabolites of plants, have volatile and natural characteristics. The biological activities of EOs have been increasing interest for many years, and the number of studies in the literature has increased in parallel with this interest. Although their antimicrobial activities are more common than other biological activities, some areas still need research. In the first stage of this chapter, the known antimicrobial activities of EOs will mainly be evaluated under the titles such as usage of EOs in combinations and encapsulation of EOs. Further, synergistic, additive, or antagonistic interactions of EO combinations will also be associated with their chemical compositions. In the second part, the review will focus on new and remarkable biological activities of EOs such as angiotensin-converting enzyme inhibitory potential, ?-amylase and ?-glucosidase inhibition potential, and xanthine oxidase inhibition potentials of essential oils. While the antihypertensive activity was correlated with the inhibition of the angiotensin-converting enzyme, antidiabetic activity has been associated with the inhibition of amylase and glucosidase activities. Moreover, inhibition of the xanthine oxidase enzyme prevents overproduction of uric acid and thus hyperuricemia. This situation is associated with antigout activity. © 2022 Elsevier B.V.en_US
dc.identifier.doi10.1016/B978-0-323-91099-6.00010-4
dc.identifier.endpage366en_US
dc.identifier.issn1572-5995
dc.identifier.scopus2-s2.0-85134510881en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage331en_US
dc.identifier.urihttps://doi.org/10.1016/B978-0-323-91099-6.00010-4
dc.identifier.urihttps://hdl.handle.net/20.500.12684/12837
dc.identifier.volume74en_US
dc.indekslendigikaynakScopusen_US
dc.institutionauthorMutlu İngök, Ayşegül
dc.language.isoenen_US
dc.publisherElsevier B.V.en_US
dc.relation.ispartofStudies in Natural Products Chemistryen_US
dc.relation.publicationcategoryKitap Bölümü - Uluslararasıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmz$2023V1Guncelleme$en_US
dc.subjectACE inhibitoryen_US
dc.subjectAntihypertensiveen_US
dc.subjectEssential oilsen_US
dc.subjectXanthine oxidase inhibitoryen_US
dc.subject?-Amylase inhibitoryen_US
dc.subject?-Glucosidase inhibitoryen_US
dc.titleAdvances in biological activities of essential oilsen_US
dc.typeBook Chapteren_US

Dosyalar